Sydney’s Tetratherix, a start-up founded by USyd researcher Ali Fathi to commercialise a new biomaterial for regenerative medicine, is mulling life on the ASX boards.
Tetratherix claims its biomaterial (pictured) can help tissue regeneration without major side effects.
Loading…